Follow
Kate Faasse
Kate Faasse
Associate Professor, University of New South Wales
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
Acute mental health responses during the COVID-19 pandemic in Australia
JM Newby, K O˘Moore, S Tang, H Christensen, K Faasse
PloS one 15 (7), e0236562, 2020
5002020
Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions
K Faasse, J Newby
Frontiers in psychology 11, 551004, 2020
3302020
Public anxiety and information seeking following the H1N1 outbreak: blogs, newspaper articles, and Wikipedia visits
Y Tausczik, K Faasse, JW Pennebaker, KJ Petrie
Health communication 27 (2), 179-185, 2012
2462012
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic review
S Colgan, K Faasse, LR Martin, MH Stephens, A Grey, KJ Petrie
BMJ open 5 (12), e008915, 2015
2222015
The nocebo effect: patient expectations and medication side effects
K Faasse, KJ Petrie
Postgraduate medical journal 89 (1055), 540-546, 2013
2142013
A comparison of language use in pro-and anti-vaccination comments in response to a high profile Facebook post
K Faasse, CJ Chatman, LR Martin
Vaccine 34 (47), 5808-5814, 2016
1732016
How common are symptoms? Evidence from a New Zealand national telephone survey
KJ Petrie, K Faasse, F Crichton, A Grey
BMJ open 4 (6), e005374, 2014
1402014
Effect of a smartphone application incorporating personalized health-related imagery on adherence to antiretroviral therapy: a randomized clinical trial
AI Perera, MG Thomas, JO Moore, K Faasse, KJ Petrie
AIDS patient care and STDs 28 (11), 579-586, 2014
1392014
The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability
R Horne, K Faasse, V Cooper, MA Diefenbach, H Leventhal, E Leventhal, ...
British journal of health psychology 18 (1), 18-30, 2013
1362013
The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects
K Faasse, T Cundy, G Gamble, KJ Petrie
Psychosomatic medicine 75 (1), 90-96, 2013
1122013
Thyroxine: anatomy of a health scare
K Faasse, T Cundy, KJ Petrie
Bmj 339, 2009
1032009
Impact of television coverage on the number and type of symptoms reported during a health scare: A retrospective pre–post observational study
K Faasse, G Gamble, T Cundy, KJ Petrie
Bmj Open 2 (4), e001607, 2012
1012012
Correlates of health-protective behavior during the initial days of the COVID-19 outbreak in Norway
JH Zickfeld, TW Schubert, AK Herting, J Grahe, K Faasse
Frontiers in psychology 11, 564083, 2020
922020
Can positive framing reduce nocebo side effects? Current evidence and recommendation for future research
K Barnes, K Faasse, AL Geers, SG Helfer, L Sharpe, L Colloca, ...
Frontiers in Pharmacology 10, 167, 2019
892019
Seeing is believing: Impact of social modeling on placebo and nocebo responding.
K Faasse, A Grey, R Jordan, S Garland, KJ Petrie
Health Psychology 34 (8), 880, 2015
722015
Unhelpful information about adverse drug reactions
K Tan, KJ Petrie, K Faasse, MJ Bolland, A Grey
Bmj 349, 2014
722014
Impact of brand or generic labeling on medication effectiveness and side effects.
K Faasse, LR Martin, A Grey, G Gamble, KJ Petrie
Health Psychology 35 (2), 187, 2016
702016
You can't always get what you want: The influence of choice on nocebo and placebo responding
H Bartley, K Faasse, R Horne, KJ Petrie
Annals of Behavioral Medicine 50 (3), 445-451, 2016
652016
The influence of side effect information framing on nocebo effects
K Faasse, A Huynh, S Pearson, AL Geers, SG Helfer, B Colagiuri
Annals of Behavioral Medicine 53 (7), 621-629, 2019
572019
Prescribing placebos: an experimental examination of the role of dose, expectancies, and adherence in open-label placebo effects
J El Brihi, R Horne, K Faasse
Annals of Behavioral Medicine 53 (1), 16-28, 2019
512019
The system can't perform the operation now. Try again later.
Articles 1–20